Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2008, p. 1558-1560, Vol. 46, No. 4
0095-1137/08/$08.00+0 doi:10.1128/JCM.02066-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
| CASE REPORT |

Department of Microbiology, University Hospital Virgen Macarena, Seville, Spain,1 Department of Microbiology, School of Medicine, University of Seville, Seville, Spain,2 Department of Internal Medicine, University Hospital Virgen Macarena, Seville, Spain3
Received 24 October 2007/ Returned for modification 13 December 2007/ Accepted 9 February 2008
The fatal outcome of levofloxacin treatment in a patient with bacteremic pneumonia caused by Streptococcus pneumoniae with a preexisting parC mutation is reported. Failure was due to the emergence of a gyrA mutation after 4 days of therapy. Problems encountered in detecting first-step mutation isolates are discussed.
Published ahead of print on 20 February 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»